These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15469598)

  • 41. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
    Garneata L
    J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is supplementary iron useful when preterm infants are treated with erythropoietin?
    Ridley FC; Harris J; Gottstein R; Emmerson AJ
    Arch Dis Child; 2006 Dec; 91(12):1036-8. PubMed ID: 17119084
    [No Abstract]   [Full Text] [Related]  

  • 43. Anemia in critical illness: insights into etiology, consequences, and management.
    Hayden SJ; Albert TJ; Watkins TR; Swenson ER
    Am J Respir Crit Care Med; 2012 May; 185(10):1049-57. PubMed ID: 22281832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythropoietin and transfusions among critically ill patients.
    Abbott KC
    JAMA; 2003 Mar; 289(12):1511-2; author reply 1512. PubMed ID: 12672765
    [No Abstract]   [Full Text] [Related]  

  • 45. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin.
    Markowitz GS; Kahn GA; Feingold RE; Coco M; Lynn RI
    Clin Nephrol; 1997 Jul; 48(1):34-40. PubMed ID: 9247776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 47. A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGEN.
    Johnson CA; Rosowski E; Zimmerman SW
    Adv Perit Dial; 1992; 8():444-7. PubMed ID: 1361844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
    Thomas C; Thomas L
    Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepcidin and anemia of the critically ill patient: bench to bedside.
    Lasocki S; Longrois D; Montravers P; Beaumont C
    Anesthesiology; 2011 Mar; 114(3):688-94. PubMed ID: 21258235
    [No Abstract]   [Full Text] [Related]  

  • 50. Anemia of inflammation in critically ill patients.
    Sihler KC; Napolitano LM
    J Intensive Care Med; 2008; 23(5):295-302. PubMed ID: 18701529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron status and the treatment of the anemia of prematurity.
    Kling PJ; Winzerling JJ
    Clin Perinatol; 2002 Jun; 29(2):283-94. PubMed ID: 12168242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iron and anemia of chronic disease.
    Weiss G
    Kidney Int Suppl; 1999 Mar; 69():S12-7. PubMed ID: 10084281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anemia of inflammation: clinical insights from mechanisms.
    Means RT
    Rinsho Ketsueki; 2013 Oct; 54(10):1596-602. PubMed ID: 24064808
    [No Abstract]   [Full Text] [Related]  

  • 54. [Selenium supplementation in critically ill patients: pharmacological issues and current evidence].
    Manzanares W; Hardy G
    Nutr Hosp; 2009; 24(4):429-36. PubMed ID: 19721922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of intravenous iron in critically ill patients with anemia.
    Leal-Noval SR; Muñoz Gómez M; Casado Méndez M
    Med Clin (Barc); 2018 Apr; 150(8):327-328. PubMed ID: 29162272
    [No Abstract]   [Full Text] [Related]  

  • 56. [Research progress of iron metabolism in critical ill patients].
    Xie L; Wang S; Pan S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):765-768. PubMed ID: 28795681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunonutrients in critically ill patients: an analysis of the most recent literature.
    Annetta MG; Pittiruti M; Vecchiarelli P; Silvestri D; Caricato A; Antonelli M
    Minerva Anestesiol; 2016 Mar; 82(3):320-31. PubMed ID: 25969140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of bacterial infections on erythropoiesis.
    Valente de Souza L; Hoffmann A; Weiss G
    Expert Rev Anti Infect Ther; 2021 May; 19(5):619-633. PubMed ID: 33092423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there a role for iron supplementation in critically ill patients?
    Muñoz M; Gómez-Ramírez S
    Med Intensiva (Engl Ed); 2019 Mar; 43(2):103-107. PubMed ID: 29656832
    [No Abstract]   [Full Text] [Related]  

  • 60. Iron control of erythroid microtubule cytoskeleton as a potential target in treatment of iron-restricted anemia.
    Goldfarb AN; Freeman KC; Sahu RK; Elagib KE; Holy M; Arneja A; Polanowska-Grabowska R; Gru AA; White Z; Khalil S; Kerins MJ; Ooi A; Leitinger N; Luckey CJ; Delehanty LL
    Nat Commun; 2021 Mar; 12(1):1645. PubMed ID: 33712594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.